Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer.

MLA

Bansal, Varun V., et al. “Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer.” Journal of the American College of Surgeons, vol. 238, no. 6, June 2024, pp. 1013–20. EBSCOhost, https://doi.org/10.1097/XCS.0000000000001028.

APA

Bansal, V. V., Belmont, E., Godley, F. 4th, Dhiman, A., Witmer, H. D., Li, S., Liao, A., Eng, O. S., Turaga, K. K., & Shergill, A. (2024). Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer. Journal of the American College of Surgeons, 238(6), 1013–1020. https://doi.org/10.1097/XCS.0000000000001028

Chicago

Bansal, Varun V, Erika Belmont, Frederick, 4th Godley, Ankit Dhiman, Hunter D Witmer, Shen Li, Andy Liao, Oliver S Eng, Kiran K Turaga, and Ardaman Shergill. 2024. “Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer.” Journal of the American College of Surgeons 238 (6): 1013–20. doi:10.1097/XCS.0000000000001028.